Universal Flu Vaccine being tested on humans
Friday, July 20th, 2007
Researchers from VIB and Ghent University are beginning Phase I of human testing of their new Universal Flu Vaccine.
that is, the candidate vaccine is being administered to a small group of healthy people in order to verify the safety of the product and to provide an initial insight into the vaccine’s effect on the human immune system.
While the external structure of all flu viruses changes each year through mutation — thus becoming unrecognizeable to our immune systems antibodies and requiring a new vaccine — all human flu viruses known carry the so-called M2 protein on their surface, and it is this which the vaccine targets.
There is much controversy concerning overvaccination. Keeping in mind that flu viruses cause 3 to 5 million hospitalizations and 250,000 to 500,000 deaths per year, and the looming threat of a pandemic flu virus like the Spanish Flu of 1918, perhaps this vaccine would be worth consideration.








